Charge-reversal nanoparticles: novel targeted drug delivery carriers - Wikidata - awgldk - TriplyDB

Charge-reversal nanoparticles: novel targeted drug delivery carriers

Charge-reversal nanoparticles: novel targeted drug delivery carriers

http://www.wikidata.org/entity/Q26740583

about

Development of antifungal therapies using nanomaterials.The new era of nanotechnology, an alternative to change cancer treatment.The impact of size and shape distributions on the electron charge transfer properties of silver nanoparticles.Could multiresponsive hollow shell-shell nanocontainers offer an improved strategy for drug delivery?Surface-enhanced Raman nanoparticles for tumor theranostics applications.Size dependent surface reconstruction in detonation nanodiamonds Nanoparticles in Medicine: A Focus on Vascular Oxidative Stress

P2860

Q38658275-EFB8DF3D-EC19-4391-A20B-2DE19F3E76AA Q42370576-5FBE6581-FC64-4537-ABAA-15643F70EEC9 Q47192819-C32543CD-6E61-4091-A5A2-2D73ED7BBE9D Q48950529-52BCF05E-00FA-41AA-8E85-BD1644A5C134 Q55076077-03736538-FE3A-42E8-B8BD-39E10E1F56D8 Q57186872-E3A9AE71-E5E7-479C-AC99-C254CB0E0502 Q57821326-E8591E61-1D36-4342-A6CD-E34797166505

P2860

Charge-reversal nanoparticles: novel targeted drug delivery carriers

http://www.wikidata.org/entity/Q26740583

description

2016 nî lūn-bûn

@nan

2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Charge-reversal nanoparticles: novel targeted drug delivery carriers

@ast

Charge-reversal nanoparticles: novel targeted drug delivery carriers

@en

Charge-reversal nanoparticles: novel targeted drug delivery carriers

@nl

type

label

Charge-reversal nanoparticles: novel targeted drug delivery carriers

@ast

Charge-reversal nanoparticles: novel targeted drug delivery carriers

@en

Charge-reversal nanoparticles: novel targeted drug delivery carriers

@nl

prefLabel

Charge-reversal nanoparticles: novel targeted drug delivery carriers

@ast

Charge-reversal nanoparticles: novel targeted drug delivery carriers

@en

Charge-reversal nanoparticles: novel targeted drug delivery carriers

@nl

P1433

Q26740583-48C9B21B-7E5C-4182-91A9-F4D7CBB01672

P1476

Q26740583-BB6A5151-6D57-423C-A68D-555742134106

P2093

Q26740583-564DC018-5364-42ED-91CD-4720A51B9DFC

Q26740583-5F13DB23-FA1A-40ED-93C8-AB869C596517

Q26740583-CC133F06-6ED0-42C0-A4B3-9E8B2B1BED19

P2860

Q26740583-0A55E23D-CD0E-4DFD-94A0-54A775F194B8

Q26740583-13D55983-D33E-407A-8FA7-1A87C1EB1D52

Q26740583-228D572E-5475-4D64-BB01-1C4E808553EB

Q26740583-2346A612-A75C-4680-A658-7A3903F86D4D

Q26740583-26653C0E-9B32-4305-9DDB-E0D38D95E990

Q26740583-30A1E79C-8490-40AE-9EBB-DC41C8BC2090

Q26740583-36768C84-D4CF-409E-9944-8C73AAC6665F

Q26740583-3F233DAB-DBB4-4382-9B61-B66BD856A4E5

Q26740583-42D70F45-6908-471B-A394-1FD79425CF68

Q26740583-448AA4E8-0B0E-42EF-95F7-871020F99033

P304

Q26740583-FEE87322-A8B8-44F0-8563-84B4FE4834E4

P31

Q26740583-A392897B-4F23-4065-90ED-10B7E162B2A1

P3181

Q26740583-7668D8D7-F9AF-4C92-AE6A-DB855E95C3B3

P356

Q26740583-7874FCE8-5BBA-4B04-B9F5-911D7F174A1B

P407

Q26740583-879645E5-7651-4A52-BAC0-27C88969D932

P433

Q26740583-10968754-5579-43FB-AA82-ACE809AE8E9F

P478

Q26740583-36EC2B91-0792-469E-974F-7BE298A79EA8

P577

Q26740583-284A6888-560A-458E-8852-28322887E927

P698

Q26740583-FF985D45-7317-472E-9632-DDDACD5458AE

P921

Q26740583-43844A60-66C9-4832-839A-95647A04B096

Q26740583-FADBD844-546A-49E5-9239-35854A25DD31

P932

Q26740583-271BE3C4-EBF4-4A84-974D-F8B5DA5E756A

P3181

P356

J.APSB.2016.05.011

P1433

Acta pharmaceutica Sinica B

P1476

Charge-reversal nanoparticles: novel targeted drug delivery carriers

@en

P2093

Chen Jiang

http://www.w3.org/2001/XMLSchema#string

Lisha Liu

http://www.w3.org/2001/XMLSchema#string

Xinli Chen

http://www.w3.org/2001/XMLSchema#string

P2860

A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics

Antibacterial resistance worldwide: causes, challenges and responses

Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting

Nano delivers big: designing molecular missiles for cancer therapeutics.

PEG-b-PCL copolymer micelles with the ability of pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin.

Liposomes targeted by fusion phage proteins

Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications.

Designing carboxymethyl cellulose based layer-by-layer capsules as a carrier for protein delivery.

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

Subcellular detection and localization of the drug transporter P-glycoprotein in cultured tumor cells.

P304

261-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1331983

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.APSB.2016.05.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27471667

http://www.w3.org/2001/XMLSchema#string

P921

P932

4951588

http://www.w3.org/2001/XMLSchema#string